gatifloxacin has been researched along with Innate Inflammatory Response in 1 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Excerpt | Relevance | Reference |
---|---|---|
" The mean peak concentration in plasma of 4." | 1.30 | A study to determine the pharmacokinetics and inflammatory fluid penetration of gatifloxacin following a single oral dose. ( Andrews, JM; Ashby, JP; Marshall, J; Wise, R, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wise, R | 1 |
Andrews, JM | 1 |
Ashby, JP | 1 |
Marshall, J | 1 |
1 other study available for gatifloxacin and Innate Inflammatory Response
Article | Year |
---|---|
A study to determine the pharmacokinetics and inflammatory fluid penetration of gatifloxacin following a single oral dose.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Cantharidin; Exudates and Transudates; Fluoroqui | 1999 |